Bone densitometry in patients with multiple myeloma

Am J Med. 1992 Dec;93(6):595-8. doi: 10.1016/0002-9343(92)90190-m.

Abstract

Purpose, patients, and methods: We performed dual-energy x-ray absorptiometry in 10 selected patients with aggressive multiple myeloma in whom substantial tumor mass reduction was achieved after high-dose chemoradiotherapy followed by autologous blood stem cell transplantation.

Results: In most cases, bone mineral density (BMD) of the spine was initially low (Mean Z score: -2.69, SEM 0.76) and dramatically increased after treatment (mean increase 16.4%; 7.7% with 95% confidence interval 2.2 to 12.2, excluding one patient whose spine BMD increased by 94.8%). In contrast, skeletal roentgenograms, computed tomographic scans, and magnetic resonance imaging did not reveal any significant improvement of patients' bone lesions.

Conclusions: In patients with multiple myeloma, bone densitometry could be a useful way to assess the efficacy of treatment on bone status.

MeSH terms

  • Absorptiometry, Photon / standards*
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Blood Component Transfusion / standards
  • Blood Transfusion, Autologous / standards
  • Bone Density
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging / standards
  • Male
  • Middle Aged
  • Multiple Myeloma / diagnostic imaging*
  • Multiple Myeloma / epidemiology
  • Multiple Myeloma / therapy
  • Neoplasm Staging
  • Radionuclide Imaging
  • Sensitivity and Specificity
  • Stem Cell Transplantation
  • Tomography, X-Ray Computed / standards
  • Treatment Outcome
  • Whole-Body Irradiation